|
Hits:6370 , posted at 2018/11/12 13:33
Dear customer:
Thank you very much for your long-term support to our company. On the occasion of the 14th national symposium on radioactive drugs and marker compounds, we sincerely look forward to your visit and await your arrival.
Exposition Information
Time：2nd - 4th Nov., 2018
Address：International academic exchange center of xiang 'an campus of xiamen university
Booth：#06
PET Peptide
|
P00130
|
NOTA-RGD
|
NOTA-Arg-Gly-Asp
|
|
P00730
|
NOTA-TATE-RGD
|
NOTA-Glu{PEG4-Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]-PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr
|
|
P22060
|
NOTA-CPCR4-2
|
Cyclo { (D-Tyr)-(D-NMe-Orn)-(AMBS-NOTA)-Arg-(2-Nal)-Gly}
|
|
P00733
|
NOTA-3PTATE-RGD
|
NOTA-(Bn-p-SCN)-PEG4-Glu{PEG4-Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]-PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr
|
|
P21600
|
NOTA-TATE-PRGD2
|
NOTA-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr-(Arg-Gly-Asp)2
|
|
P01400
|
PSMA-617
|
DOTA-Amc-Nal-Lys-CO-Glu-OH
|
|
P21601
|
DOTA-TATE
|
DOTA-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr [Disulfide Bond: Cys³-Cys⁸]
|
|
P01600
|
NODAGA-LM3
|
NODAGA-p-Cl-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
P01601
|
DOTA-LM3
|
DOTA-p-Cl-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
P00381
|
NODAGA-JR11
|
NODAGA -Cpa-c[D-Cys-Aph(Hor)-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
P01602
|
DOTA-JR10
|
DOTA-p-NO2-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
P01603
|
NODAGA-JR10
|
NODAGA-p-NO2-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
P00801
|
NOTA-MAL-Cys40-Exendin-4
|
NOTA-MAL-Cys40-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
|
|
P00802
|
NOTA-Exendin-4
|
NOTA -His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
|
|
P00734
|
|
NOTA-Glu-{PEG₄-Cyclo[Arg-Gly-Asp-(D-Phe)-Lys]}₂
|
|
P00131
|
T140
|
Arg-Arg-Nal-Cys-Tyr-Arg-Lys-(D-Lys)-Pro-Tyr-Arg-Cit-Cys-Arg [Disulfide Bond: Cys⁴-Cys¹³]
|
|
P22061
|
FC131
|
(D-Tyr)-Arg-Arg-(2-Nal)-Gly [Lactam Bond: (D-Tyr)¹-Gly⁵]
|
|
CS9418
|
NOTA-3PRGD2
|
NOTA-PEG4-Glu{PEG4-cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}₂
|
|
CS15388
|
PSMA-11
|
Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
|
|
CS11123
|
DOTA-JR11
|
DOTA-Cpa-c[D-Cys-Aph(Hor)-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS15452
|
(NeoBomb1)
|
DOTA-pABzA-DIG-(D-Phe)-Gln-Trp-Ala-Val-Gly-His-NCH[CH₂-CH(CH₃)₂]₂
|
|
CS6863
|
|
DOTA-PEG4-(4-amino-1-carboxymethyl-piperidine)-(D-Phe)-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH₂
|
|
CS7645
|
|
DOTA-(NMe-β-Alanine)-(4-amino-1-carboxymethyl-piperidine)-(D-Phe)-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH₂
|
|
CS9409
|
DOTA-Nal³-Octreotide
|
DOTA-(D-Phe)-Cys-(1-Nal)-(D-Trp)-Lys-Thr-Cys-Thr-ol [Disulfide Bond: Cys³-Cys⁸]
|
|
CS12890
|
[DOTA-WT-pHLIP(D)]
|
DOTA-(Bn-pSCN)-Ala-Cys-Glu-Gln-Asn-Pro-Ile-Tyr-Trp-Ala-Arg-Tyr-Ala-Asp-Trp-Leu-Phe-Thr-Thr-Pro-Leu-Leu-Leu-Leu-Asp-Leu-Ala-Leu-Leu-Val-Asp-Ala-Asp-Glu-Gly-Thr [All D amino acids]
|
|
CS12891
|
[DOTA-var3-pHLIP(D)]
|
DOTA-(Bn-pSCN)-Ala-Cys-Asp-Asp-Gln-Asn-Pro-Trp-Arg-Ala-Tyr-Leu-Asp-Leu-Leu-Phe-Pro-Thr-Asp-Thr-Leu-Leu-Leu-Asp-Leu-Leu-Trp [All D amino acids]
|
|
CS12892
|
[DOTA-var7-pHLIP(D)]
|
DOTA-(Bn-pSCN)-Ala-Cys-Glu-Glu-Gln-Asn-Pro-Trp-Ala-Arg-Tyr-Leu-Glu-Trp-Leu-Phe-Pro-Thr-Glu-Thr-Leu-Leu-Leu-Glu-Leu [All D amino acids]
|
|
CS6473
|
[NOTA-WT-pHLIP(D)]
|
NOTA-(Bz-SCN)-Ala-Cys-Glu-Gln-Asn-Pro-Ile-Tyr-Trp-Ala-Arg-Tyr-Ala-Asp-Trp-Leu-Phe-Thr-Thr-Pro-Leu-Leu-Leu-Leu-Asp-Leu-Ala-Leu-Leu-Val-Asp-Ala-Asp-Glu-Gly-Thr [All amino acids in D]
|
|
CS6474
|
[NOTA-Var7-pHLIP(D)]
|
NOTA-(Bz-SCN)-Ala-Cys-Glu-Glu-Gln-Asn-Pro-Trp-Ala-Arg-Tyr-Leu-Glu-Trp-Leu-Phe-Pro-Thr-Glu-Thr-Leu-Leu-Leu-Glu-Leu [All amino acids in D]
|
|
CS6475
|
[NOTA-Var3-pHLIP(D)]
|
NOTA-(Bz-SCN)-Ala-Cys-Asp-Asp-Gln-Asn-Pro-Trp-Arg-Ala-Tyr-Leu-Asp-Leu-Leu-Phe-Pro-Thr-Asp-Thr-Leu-Leu-Leu-Asp-Leu-Leu-Trp [All amino acids in D, Var3-3D]
|
|
CS9403
|
|
NOTA-Glu-{PEG₄-Cyclo[Arg-Gly-Asp-(D-Phe)-Lys]}₂
|
|
CS9441
|
(IMP466)
|
NOTA-(D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-OL [Disulfide Bond: Cys³-Cys⁸]
|
|
CS9540
|
(NOTA-3P-TATE-RGD2)
|
NOTA-(Bn-p-SCN)-PEG4-Glu[PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr]-PEG4-Glu-{Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}₂ [Disulfide Bond: Cys-Cys]
|
|
CS13081
|
(NOTA-Tyr-TATE)
|
NOTA-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr [Disulfide Bond: Cys²-Cys⁷]
|
|
CS6649
|
|
NODAGA-(4-amino-1-carboxymethyl-piperidine)-(D-Phe)-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
|
|
CS11070
|
|
NODAGA-PEG4-Arg-Arg-Pro-Dmt-Tle-Leu
|
|
CS11072
|
|
Cyclo{(D-Tyr)-[NMe-D-Orn-(4-(aminomethyl)
benzoic acid, NODAGA)]-Arg-(2-Nal)-Gly}
|
|
CS11071
|
|
Cyclo[(D-Tyr)-D-NMe-Orn(AMBS-DOTA)-Arg-(2-Nal)-Gly]
|
|
CS11129
|
(NODAGA-PEG-NT-XII )
|
NODAGA-PEG4-Arg-(NMe-Arg)-Pro-Tyr-Tle-Leu [Tle: α-t-butyl-Gly, 131.29 g/mol]
|
|
CS7457
|
|
Ac-Lys(NODAGA)-Pro-(Me-Arg)-Arg-Pro-Tyr-Tle-Leu
|
|
CS7573
|
|
NODAGA-PEG4-Arg-Arg-Pro-Tyr-Tle-Leu
|
|
CS13120
|
|
DOTAGA-(D-Phe)-(D-Phe)-(D-Lys)
|
|
CS13608
|
|
{[(DOTAGA)2-Lys]2Lys}2Lys-Lys(Ahx-Ahx)-NH2
|
|
CS9243
|
DOTA-Ahx-Lys40 –Exendin
|
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser –(Lys40-Ahx-DOTA)
|
希施简介
CSBio has brought together 25 years' experience serving the life science community, the only professional company who has Total Peptide Solution for every peptide users! CSBio also has a full scale, FDA inspected GMP peptide production facility and holds a Drug Manufacturing License from the state of California. CSBio is the only GMP certified peptide synthesizers manufacturer in the world.
CSBio (Shanghai) Ltd
China (Shanghai) Pilot Free Trade Zone, 85 Faladi Road, Building 2, Room
Email：info@csbiochina.com
Tel：+8621-50781653/50781655
Fax：+8621-50781652/021-50781656
Website：www.csbiochina.com www.csbio.com
|
沪公网安备 31011502005552号
沪ICP备13005633号-1
Technical information